Skip to main content
EDEN RESEARCH PLC logo

EDEN RESEARCH PLC — Investor Relations & Filings

Ticker · EDEN ISIN · GB0001646941 LEI · 213800ZWTYTVQQSM3J85 IL Manufacturing
Open in API
Filings indexed 351 across all filing types
Latest filing 2024-11-07 Regulatory Filings
Country GB United Kingdom
Listing IL EDEN

About EDEN RESEARCH PLC

https://www.edenresearch.com/

Eden Research plc develops and supplies sustainable biopesticides and plastic-free encapsulation technologies. The company's core innovation is its proprietary Sustaine® microencapsulation system, which protects and delivers naturally occurring, plant-based active ingredients known as terpenes. Its products serve three primary markets: crop protection, animal health, and consumer products. The crop protection portfolio includes the biofungicide Mevalone® and the bionematicide Cedroz®, designed for applications such as foliar disease control, soil pest management, and post-harvest treatments. In animal health and consumer goods, its technologies are used in products like shampoos, flea and tick control, deodorants, and head-lice treatments.

Recent filings

Filing Released Lang Actions
Trading Update
Regulatory Filings Classification · 98% confidence The document starts with an RNS Number and a date, indicating a regulatory announcement via the London Stock Exchange's RNS system. The content provides a 'Trading Update' with preliminary financial figures for FY2024 (revenue, operating loss, cash position) and an outlook for FY2025. This structure—providing key financial highlights before the full report is due—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or a comprehensive Interim Report (IR), as it focuses on expected year-end figures and operational updates rather than audited or detailed period-end statements. Since it is a formal announcement of preliminary results, ER is the most appropriate classification. The presence of the RNS header confirms it is a regulatory filing, but ER is more specific than the general RNS code.
2024-11-07 English
Ecovelex Approval in Italy
Earnings Release Classification · 99% confidence The document is identified by the RNS Number header and explicitly states it is an announcement released via RNS, the news service of the London Stock Exchange. The content is a press release announcing a regulatory approval (Ecovelex™ 2024 Approval in Italy) and includes contact information for financial PR and nominated advisors, typical of a market announcement. Since it is a general regulatory announcement that doesn't fit specific categories like Director's Dealing (DIRS), Earnings Release (ER), or Capital Change (SHA), the most appropriate classification is the general regulatory filing category, RNS. FY 2024
2024-11-07 English
OTCQB exchange update
Delisting Announcement Classification · 100% confidence The document is an official announcement disseminated via RNS (RNS Number: 3774H) on October 8, 2024. The core subject is the announcement that 'Eden Research plc... has, as of today, delisted from the OTCQB exchange in the US.' This is a specific corporate action related to the company's stock exchange listing status. This type of official notice, which is not a full financial report (10-K, IR), a dividend notice (DIV), or a management change (MANG), fits best under the general category for regulatory announcements that do not have a more specific code. While 'Delisting Announcement' (DLST) is a possibility, the document structure, use of RNS headers, and the fact that it is a brief, formal update often places such non-financial, non-governance specific regulatory news into the general 'Regulatory Filings' category (RNS) when a more specific code like DLST is not explicitly required or if the filing is primarily an RNS dissemination. However, given the explicit definition for 'Delisting Announcement (Code: DLST)' and the clear content stating the delisting, DLST is the most precise fit. The document length is moderate (5465 chars), but the content is purely the announcement itself, not a detailed report.
2024-10-08 English
Half yearly Report
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Half Yearly Report' and explicitly states it covers the 'six months ended 30 June 2024'. It contains detailed financial highlights, business performance analysis, and management commentary. It is a comprehensive interim financial report, not merely an announcement or a certification, thus fitting the definition of an Interim / Quarterly Report (IR). H1 2024
2024-09-23 English
Notice of Results
Regulatory Filings Classification · 98% confidence The document is a formal announcement released via RNS (London Stock Exchange news service), indicated by the 'RNS Number' and the concluding boilerplate text referencing RNS and the FCA. The core content is titled 'Notice of Results' and explicitly states that the company 'will announce its interim financial results for the six months ended 30 June 2024 on 23 September 2024.' It also mentions a subsequent investor presentation on the results date. Since this document is an announcement *about* the upcoming release of the interim financial results, rather than the comprehensive interim report itself (which would be classified as 'IR'), it fits the definition of a Report Publication Announcement (RPA). It is not a general regulatory filing (RNS) because it announces a specific corporate event (the release of results).
2024-09-20 English
Nematicide Approval in Greece
Legal Proceedings Report Classification · 99% confidence The document begins with 'RNS Number : 3817C' and is dated 02 September 2024. It announces a specific operational update: 'Nematicide Approval in Greece' for one of their products (Cedroz Ô). The text is a formal announcement distributed via RNS, the news service of the London Stock Exchange, and it is relatively short (6450 chars) and focused on a single piece of news rather than being a comprehensive report (like a 10-K or IR). Since it is a general regulatory announcement distributed through the RNS system that doesn't fit neatly into specific categories like ER, DIV, or MANG, the most appropriate classification is the general regulatory filing category.
2024-09-02 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.